ORCID as entered in ROS

Select Publications
2007, 'Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma', Oncogene, 26, pp. 1920 - 1931, http://dx.doi.org/10.1038/sj.onc.1209981
,2006, 'Pulmonary Langerhans cell histiocytosis: A variable disease in childhood', Pediatric Blood and Cancer, 47, pp. 889 - 893, http://dx.doi.org/10.1002/pbc.20676
,2006, 'Childhood brain tumour information on the Internet in the Chinese language', Child S Nervous System, 22, pp. 346 - 351, http://dx.doi.org/10.1007/s00381-005-1238-x
,2006, 'Cutaneous Langerhans cell histiocytosis in children under one year', Pediatric Blood and Cancer, 46, pp. 66 - 71, http://dx.doi.org/10.1002/pbc.20479
,2005, 'A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study', Clinical Cancer Research, 11, pp. 672 - 677, http://dx.doi.org/10.1158/1078-0432.672.11.2
,2005, 'Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in children', Canadian Journal of Clinical Pharmacology, 12, pp. e222 - e228
,2004, 'Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant? [3]', Bone Marrow Transplantation, 34, pp. 275 - 276, http://dx.doi.org/10.1038/sj.bmt.1704557
,2004, 'Factors Influencing Survival in Children with Recurrent Neuroblastoma', Journal of Pediatric Hematology Oncology, 26, pp. 227 - 232, http://dx.doi.org/10.1097/00043426-200404000-00003
,2003, 'Analysis of Paediatric Neuro-Oncological Information on the Internet in German Language', Klinische Padiatrie, 215, pp. 352 - 357, http://dx.doi.org/10.1055/s-2003-45491
,2003, 'Quality of childhood brain tumour information on the Internet in French language', Bulletin Du Cancer, 90, pp. 650 - 655
,2002, 'Neuroblastoma: A single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors', Pediatric Hematology and Oncology, 19, pp. 79 - 89, http://dx.doi.org/10.1080/08880010252825669
,2023, 'FACTORS INFLUENCING UPTAKE OF INDIVIDUALISED PRECISION MEDICINE TREATMENT RECOMMENDATIONS FOR HIGH-RISK PAEDIATRIC ONCOLOGY PATIENTS: RESULTS FROM THE PRISM ENGAGEMENT WITH CLINICIANS (PRE-CLIN) STUDY', in PEDIATRIC BLOOD & CANCER, WILEY
,2023, 'PEDIATRIC DIFFUSE MIDLINE GLIOMA PATIENTS HAVE A HIGH PREVALENCE OF TARGETABLE GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION AND MISMATCH REPAIR GENES', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S133 - S134
,2022, 'Establishment and application of patient-derived xenograft models for personalised medicine in paediatric cancer', Sydney, presented at Children’s Cancer Institute - Research Symposium 2022, Sydney, 06 December 2022
,2022, 'MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS', Vancouver, Canada, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting 2022, Vancouver, Canada, 17 November 2022
,2020, 'Supporting clinical decision-making for PI3K/AKT/MTOR inhibitors for high-risk paediatric and AYA sarcoma', Virtual, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting 2020, Virtual, 18 November 2020
,2020, 'Supporting clinical decision-making for PI3K/AKT/MTOR inhibitors for high-risk paediatric sarcoma patients', Virtual, presented at KCA Symposium 2020, Virtual, 17 September 2020
,2020, 'Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies', in Cancer Research, American Association for Cancer Research (AACR), pp. IA13 - IA13, http://dx.doi.org/10.1158/1538-7445.pedca19-ia13
,2020, 'Precision medicine for high-risk paediatric and AYA sarcomas', Lorne, presented at Lorne Cancer 2020, Lorne, 13 February 2020
,2019, 'Personalised medicine for high-risk paediatric and AYA sarcoma patients', Tokyo, Japan, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting, Tokyo, Japan, 13 November 2019, https://www.ctos.org/Portals/0/PDF/2019%20CTOS%20Final%20Program.pdf
,2013, 'GENETIC BASIS OF TELOMERE DISORDERS', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Technol, Sydney, pp. 315 - 315, presented at 8th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Technol, Sydney, 08 May 2013 - 10 May 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325102500012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Skeletal Langerhans Cell Histiocytosis in children: Late effects and health-related quality of life in long-term survivors', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 751 - 751, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246239900032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Differential modulation of p73 isoforms by COX inhibitor in neuroblastoma', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 601 - 601, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246013900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Radiologically aggressive langerhans cell histiocytosis bone lesions (LCH) in children', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 195 - 196, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222479000028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'The natural history and long-term complications of patients with bone Langerhans cell histiocytosis (LCH)', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 204 - 204, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222479000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'What is the significance of negative MIBG scan and urine catecholamines in children with neural crest tumors?', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 812S - 812S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512403223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Evaluation of the risk of recurrence and diabetes insipidus in patients with langerhans cell histocytosis involving the skeletal system', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, CA, San Francisco, pp. 301A - 301A, presented at Annual Meeting of the Pediatric-Academic-Societies, CA, San Francisco, 04 May 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220591101778&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2003, 'A retrospective analysis of factors contributing to survival in children with relapsed neuroblastoma', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, WASHINGTON, SEATTLE, pp. 270A - 270A, presented at Annual Meeting of the Pediatric-Academic-Society, WASHINGTON, SEATTLE, 03 May 2003 - 06 May 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000181897901543&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'Cord blood transplant as rescue therapy for engraftment failure after unrelated BMT.', in BLOOD, AMER SOC HEMATOLOGY, PENNSYLVANIA, PHILADELPHIA, pp. 465B - 465B, presented at 44th Annual Meeting of the American-Society-of-Hematology, PENNSYLVANIA, PHILADELPHIA, 06 December 2002 - 10 December 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179184801977&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Matched sibling donor allogeneic bone marrow transplantation for pediatric acute myeloid leukemia (AML) of different risk groups: A decision analysis approach.', in BLOOD, AMER SOC HEMATOLOGY, pp. 417A - 417A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172134101754&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Precision Medicine for High-Risk Paediatric Cancers - Molecular Tumour Board Recommendations and Treatment Responses (Zero Childhood Cancer Program)', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000708132100110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, 'Individualized-tumor-informed panel approach enables ultra-sensitive ctDNA-based minimal residue disease monitoring for high-risk pediatric cancers', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 30, presented at AACR Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation, CA, San Diego, 13 November 2024 - 16 November 2024, http://dx.doi.org/10.1158/1557-3265.LIQBIOP24-B009
,2024, 'Precision-guided treatment improves outcomes for children with high-risk cancers', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, Barcelona, Vol. 211, pp. S162 - S163, presented at 36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR), SPAIN, Barcelona, 23 October 2024 - 25 October 2024, http://dx.doi.org/10.1016/j.ejca.2024.114946
,2024, 'Clinical utility of real-time comprehensive molecular profiling in childhood brain tumors', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CANADA, Toronto, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research, CANADA, Toronto, 05 September 2024 - 08 September 2024, http://dx.doi.org/10.1158/1538-7445.PEDIATRIC24-B012
,2024, 'Enhanced disease detection using single cell RNAseq in children with brain cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CANADA, Toronto, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research, CANADA, Toronto, 05 September 2024 - 08 September 2024, http://dx.doi.org/10.1158/1538-7445.PEDIATRIC24-A044
,2024, 'High-risk pediatric cancer models in zebrafish, mouse and short-term culture predict individual patient responses to therapy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CANADA, Toronto, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research, CANADA, Toronto, 05 September 2024 - 08 September 2024, http://dx.doi.org/10.1158/1538-7445.PEDIATRIC24-B007
,2024, 'Implementing ultra-sensitive, ctDNA-based liquid biopsy for disease monitoring in paediatric tumours', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CANADA, Toronto, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research, CANADA, Toronto, 05 September 2024 - 08 September 2024, http://dx.doi.org/10.1158/1538-7445.PEDIATRIC24-A045
,2024, 'Increasing the clinical utility of transcriptome analysis in high-risk childhood precision oncology', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CANADA, Toronto, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research, CANADA, Toronto, 05 September 2024 - 08 September 2024, http://dx.doi.org/10.1158/1538-7445.PEDIATRIC24-B014
,2024, 'LOW GRADE GLIOMA CAUGHT IN TRANSFORMATION: UTILITY OF COMPREHENSIVE GENOMIC PROFILING IN PEDIATRIC LI FRAUMENI SYNDROME ASSOCIATED HIGH-GRADE GLIOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, PA, Philadelphia, Vol. 26, presented at International Symposium on Pediatric Neuro-Oncology (ISPNO), PA, Philadelphia, 29 June 2024 - 02 July 2024, http://dx.doi.org/10.1093/neuonc/noae064.334
,2024, 'PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, PA, Philadelphia, Vol. 26, presented at International Symposium on Pediatric Neuro-Oncology (ISPNO), PA, Philadelphia, 29 June 2024 - 02 July 2024, http://dx.doi.org/10.1093/neuonc/noae064.129
,2024, 'PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, PA, Philadelphia, Vol. 26, presented at International Symposium on Pediatric Neuro-Oncology (ISPNO), PA, Philadelphia, 29 June 2024 - 02 July 2024, http://dx.doi.org/10.1093/neuonc/noae064.101
,2024, 'Development of high-throughput 3D bioprinted pediatric models for precision medicine', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-5475
,, 2024, 'DIPG-48. PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA', in Neuro-oncology, Vol. 26
2023, 'Tumour profiling frequently informs the interpretation of germline variants arising from paired analysis in children and young people', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, SCOTLAND, Glasgow, Vol. 32, pp. 572 - 572, presented at 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), SCOTLAND, Glasgow, 10 June 2023 - 13 June 2023
,2023, 'True bench-to-bedside science: An international pilot study modeling hard-to-cure pediatric cancers to prioritize therapeutic intervention', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, FL, Orlando, Vol. 83, presented at 114th Annual Meeting of the American-Association-for-Cancer-Research (AACR), FL, Orlando, 14 April 2023 - 19 April 2023, http://dx.doi.org/10.1158/1538-7445.AM2023-4670
,2023, 'THE PATHOLOGIC FEATURES OF RELAPSED BRAF-V600E LANGERHANS CELL HISTIOCYTOSIS WITH A CD163 PHENOTYPE', in PEDIATRIC BLOOD & CANCER, WILEY, Vol. 70, pp. S4 - S4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000904088900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Abstract 3044: The unexplored immune landscape of high-risk pediatric cancers', in Cancer Research, American Association for Cancer Research (AACR), Vol. 81, pp. 3044 - 3044, http://dx.doi.org/10.1158/1538-7445.am2021-3044
,2021, 'The unexplored immune landscape of high-risk pediatric cancers.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 81, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021
,2020, 'PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Vol. 22, pp. 302 - 302, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606080100118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Abstract A03: Prevalence and spectrum of germline mutations in children with high-risk cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 80, pp. A03 - A03, http://dx.doi.org/10.1158/1538-7445.pedca19-a03
,